If these new treatments aren’t used more frequently, this isn’t because they don’t work. The main obstacle is that they won’t increase the profits of drug companies, on which, in the absence of adequate government funding, our professional organizations, conferences, journals, research, and teaching institutions have become so dependent.
如果这些新的疗法没有被更多的使用，并不是因为它们效果不好。最主要的障碍是它们不会增加制药公司的收益。而在政府资金支持不足的情况下，我们许多的专业组织、会议、学术刊物、研究和教学机构在很大程度上都要依靠制药公司的赞助。